Results 21 - 30 of 122
Researchers
| Name | Track | Location | View profile |
|---|---|---|---|
| Biomedical Engineering and Physiology, Clinical and Translational Science | Florida | ||
IntroductionDr. Bryan Taylor is an Associate Professor of Medicine and Consultant in Cardiovascular Medicine at Mayo Clinic in Florida, where he serves as Program Director for Cardiopulmonary Rehabilitation and leads the Clinical and Performance Cardiopulmonary Physiology Laboratory. His research focuses on exercise physiology, cardiopulmonary exercise testing, pulmonary vascular disease, rehabilitation, and exercise-based strategies to improve cardiovascular and pulmonary health. Dr. Taylor has mentored undergraduate, graduate, medical, and postdoctoral trainees and is passionate about helping mentees develop expertise in research design, scientific writing, data analysis, critical thinking, and career development. |
|||
| Biochemistry and Molecular Biology | Minnesota | ||
IntroductionCaitlin B. Conboy, M.D., Ph.D., is a medical oncologist and physician scientist focused on improving the care of patients with hepatobiliary cancers. She completed Internal Medicine Residency and Hematology and Oncology Fellowship at Mayo Clinic, where she is an Assistant Professor of Medical Oncology. Dr. Conboy runs an active basic and translational research program focused on epigenetic mechanisms in cholangiocarcinoma. She is also a principal investigator for prospective clinical trials focused on cholangiocarcinoma and hepatocellular carcinoma. |
|||
| Biomedical Engineering and Physiology, Clinical and Translational Science, Neuroscience | Minnesota | ||
Introduction
Carlos B. Mantilla, M.D., Ph.D., is a consultant in the Department of Anesthesiology and Perioperative Medicine, with a joint appointment in the Department of Physiology and Biomedical Engineering. He holds the academic rank of professor of anesthesiology and physiology, Mayo Clinic College of Medicine and Science.
|
|||
| Virology and Gene Therapy | Minnesota | ||
IntroductionI have a joint appointment in the Departments of Molecular Medicine and Immunology. I am Associate Professor of Molecular Medicine and Director of Mayo Clinic’s High Containment BSL3 Research Facility. I am Associate Director of the VGT Track. I am virologist and have received my Ph.D. at the University of Munich, Germany. Before joining Mayo Clinic, I was a Research Group Leader at the Paul-Ehrlich-Institute in Langen, Germany. My Viro-Immunology Research Program focuses on studying virus-host interactions at the level of innate and adaptive immune responses with the goal to design novel preventative and therapeutic antiviral approaches that could also be utilized for the treatments of cancer or autoimmune disorders. |
|||
| Biochemistry and Molecular Biology, Biomedical Engineering and Physiology, Clinical and Translational Science, Regenerative Science | Minnesota | ||
|
|
|||
| Clinical and Translational Science | Arizona | ||
IntroductionMy research program integrates cardiopulmonary physiology, digital health technologies, and translational clinical research to develop and implement scalable approaches for physiologic monitoring, remote assessment, and intervention delivery across diverse populations. My work combines expertise in exercise physiology, cardiopulmonary exercise testing (CPET), physiologic phenotyping, and wearable technologies to characterize physiologic responses in both controlled laboratory and real-world settings. I have extensive experience conducting translational studies that incorporate remote physiologic monitoring, field-based data collection, and longitudinal assessment of cardiopulmonary function and physiologic stress. Able to host for rotations |
|||
| Biomedical Engineering and Physiology | Minnesota | ||
IntroductionMy research interests revolve around CT imaging technology and its many clinical applications. As director of Mayo Clinic's CT Clinical Innovation Center, I lead a multidisciplinary team on projects seeking to detect and quantify disease using CT imaging. The first whole-body, high-flux photon-counting CT system was installed in my lab in 2014, and I have played a key role in the development of photon-counting CT and its applications since that time. I am a fellow of the American College of Radiology, the American Association of Physicists in Medicine, and the American Institute for Medical and Biological Engineering. I have over 500 peer-reviewed papers and multiple NIH grants related to CT imaging. |
|||
| Biomedical Engineering and Physiology, Clinical and Translational Science, Regenerative Science | Minnesota | ||
IntroductionI am a professor of physiology and BME and direct the Tissue Repair and Mechanobiology Lab. We are a multidisciplinary team focused on tissue fibrosis and repair, with particular interest in fibroblast and matrix biology. Our lab works across the discovery to translation spectrum, bridging cellular and molecular studies with human disease models. Our training focus is rigorous science within a personalized environment that facilitates broad exploration of career options. My goal is for mentees to find fulfilling careers in science and medical research. As indicators of success, I have trained multiple students and fellows over the past few years who have gone on to faculty and research scientist positions in academia and industry. |
|||
| Biochemistry and Molecular Biology | Minnesota | ||
IntroductionDavid D. Chen, Ph.D., studies advanced cancer therapies by understanding genomic, epigenomic and metabolomic regulators and their networks. He leads the Laboratory of Gene Editing and Cellular Engineering and the Genetic Screening and Engineering Core. The lab aims to investigate gene expression, epigenetic landscape, cellular metabolism and genome integrity under normal and disease conditions, striving to develop therapeutic opportunities for leukemia and other cancers. He is particularly focused on developing new approaches to use the CRISPR-based gene-editing tools. |
|||
| Biochemistry and Molecular Biology | Florida | ||
IntroductionMy lab studies how aging, hormones, inflammation, and matrix remodeling reshape breast tissue into the "soil" that lets cancer begin and how we can intercept it. Drawing on one of the nation's largest benign breast disease cohorts plus matched tissue, organoids, and cell models, we use spatial imaging, single-cell methods, and 3D culture to find the cells and neighborhoods that drive early progression and disparities. Students here own a publishable project from day one and train in both wet-lab spatial biology and computational analysis, with weekly mentoring on experiments, writing, and career. I'm looking for curious people who like to build, protocols, code, and ideas, and want their work to matter for patients. |
|||